SCHEMBL5425307

SCHEMBL5425307

COc1ccc2[nH]c(-c3ccccc3)c(CN3CCC(c4c(C)cccc4C)CC3)c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.51
HTR1D P28221 1/20 0.51
SLC6A4 P31645 1/20 0.51
HTR7 P34969 1/20 0.51
HTR5A P47898 1/20 0.51
HTR6 P50406 1/20 0.51
MTNR1A P48039 3/20 0.50
MTNR1B P49286 3/20 0.50
HTR2A P28223 1/20 0.50
TLR9 Q9NR96 3/20 0.49
TLR7 Q9NYK1 2/20 0.49
KDM4E B2RXH2 3/20 0.49
ALDH1A1 P00352 3/20 0.49
HSD17B10 Q99714 3/20 0.49
HPGD P15428 2/20 0.49
TUBB4A P04350 1/20 0.48
TUBB P07437 1/20 0.48
TUBA3C P0DPH7 1/20 0.48
TUBA1B P68363 1/20 0.48
TUBA4A P68366 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5419291 0.89 TLR9 (0.54) HTR7HTR6HTR2ATLR9TLR7
SCHEMBL5434438 0.87 HTR2A (0.62) HTR2ATLR9KDM4EALDH1A1DRD2
SCHEMBL5421052 0.86 HTR2A (0.52) HTR1ASLC6A4HTR7HTR2ATLR9
SCHEMBL5423746 0.86 OPRM1 (0.57) HTR2ATLR9TLR7KDM4EALDH1A1
Hydrochloric Acid SCHEMBL5417603 0.85 HTR2A (0.51) HTR1ASLC6A4HTR7HTR2ATLR9
SCHEMBL5434473 0.81 HTR2A (0.47) SLC6A4HTR2ATLR9TLR7KDM4E
SCHEMBL5427688 0.80 HTR2A (0.53) HTR2ATLR9TLR7DRD2DRD4
SCHEMBL5417696 0.79 PLA2G2A (0.49) HTR6ALDH1A1
SCHEMBL5416930 0.79 TLR9 (0.56) HTR7HTR6HTR2ATLR9TLR7
SCHEMBL5424650 0.79 HTR2A (0.55) HTR2ATLR9KDM4EALDH1A1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197603-A1 Substituted indole ligands for the orl-1 receptor GLAXOSMITHKLINE S.P.A. (IT) 2007-08-23 US claimed
US-20070197603-A1 Substituted indole ligands for the orl-1 receptor GLAXOSMITHKLINE S.P.A. (IT) 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197603-A1 Substituted indole ligands for the orl-1 receptor OGFRL1, OPRL1, ORMDL3 HTR1A 27/4885HTR1D 32/4885SLC6A4 539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.